Huang Jianfeng signed a Share Transfer Agreement to acquire a 5.99% stake in Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd. for approximately CNY 150 million on July 25, 2022. Under the terms, Huang Jianfeng will acquire 12,279,500 shares at a price of CNY 12.05 per share. The consideration will be paid as, within three working days of the agreement, Huang Jianfeng will pay CNY 49,388,149 and within ten working days after the completion will pay the remaining CNY 98,579,826.

After the transaction, the shareholding ratio of Saihai (Shanghai) Health in Thalys Medical Technology will be reduced from 27.73% to 21.74% stake whereas Huang Jianfeng will hold 5.99% stake in Thalys Medical Technology.